Imaging in Movement Disorders

Keyphrases

• Parkinson's Disease 100%
• Movement Disorders 100%
• Positron Emission Tomography/computed Tomography (PET/CT) 100%
• Spontaneous Excitatory Postsynaptic Current (sEPSC) 66%
• Imaging Modalities 66%
• Radiotracer 66%
• Striatal 66%
• Single-photon Emission Computed Tomography (SPECT) 33%
• Disease Progression 33%
• Disease Pathology 33%
• Axon 33%
• Disease Severity 33%
• Functional Consequences 33%
• Differential Diagnosis 33%
• Parkinsonism 33%
• Early Parkinson's Disease 33%
• Moderate to Severe 33%
• Dementia 33%
• Clinical Examination 33%
• Clinical Application 33%
• Alpha-synuclein (α-syn) 33%
• Diagnostic Utility 33%
• Disease-modifying Therapy 33%
• Clinical Utility 33%
• Clinical Diagnosis 33%
• Neuroimaging 33%
• Multimodal Imaging 33%
• Clinical Symptoms 33%
• Misfolding 33%
• Vesicular Acetylcholine Transporter (VAChT) 33%
• Objective Biomarker 33%
• MRI Sequences 33%
• Single-photon Emission Computed Tomography Imaging 33%
• Current Research Status 33%
• Nigrostriatal System 33%
• Parkinsonian Syndromes 33%
• Nigral Dopaminergic Neuron 33%
• Prodromal Parkinson's Disease 33%
• Neuromelanin-sensitive Magnetic Resonance Imaging (NM-MRI) 33%

Medicine and Dentistry

• Parkinson's Disease 100%
• Stereotypic Movement Disorder 100%
• Positron Emission Tomography 60%
• Single-Photon Emission Computed Tomography 40%
• Magnetic Resonance Imaging 40%
• Pathophysiology 40%
• Radioactive Tracer 40%
• Parkinsonism 40%
• Diseases 40%
• Biological Marker 20%
• Disease Severity 20%
• Differential Diagnosis 20%
• Clinical Examination 20%
• Multimodal Imaging 20%
• Vesicular Acetylcholine Transporter 20%
• Dopaminergic Neuron 20%
• Neuromelanin 20%
• Axon 20%
• Synuclein 20%
• Clinical Symptom 20%